Gerresheimer has developed a new dropper insert for modern drugs with low viscosity for ophthalmology, which prevents the drug from flowing out uncontrollably during use.
Eye diseases are increasing due to the aging of the population and some specific trends in the way we live and work. Especially the work in front of screens often leads to increased eye diseases which require regular treatment with eye drops. To address this topic pharma companies have developed new ophthalmic treatments.
The new generation of eye drop solutions have modified properties compared to the former water-based eye-drop solutions to improve the efficiency and the pharmaceutical effectiveness. For such eye-drop formulations the function of a conventional eyedropper requires a modification to prevent uncontrolled dropping when the patient turns the eyedropper to release the droplets.
“With DropControl, Gerresheimer offers a solution to enable the use of conventional eyedropper systems in combination with the new eye drop solutions with very low viscosity“, says Niels Düring, Global Executive Vice President at Gerresheimer Plastic Packaging.
As an extended service, after the production of the eye dropper systems, Gerresheimer provides gamma irradiation treatment following the ISO 11137 with VDmax 17,5 kGr as validated process. The aim of gamma irradiation is to reduce the bacterial preload before filling.
